DGX vs NOV · P/E 22, rev $5.94B vs P/E 86, rev $8.74B
Quest Diagnostics Incorporated (DGX) versus NOV Inc. (NOV) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
NOV Inc. (NOV) is a oil & gas equipment & services company listed on US.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported NOV revenue for 2025-12-31 was $8.74B. Net income was $145.0M. Revenue was down 1.4% from 2024-12-31 to 2025-12-31. NOV currently screens at market cap $7.70B and trailing P/E 85.8.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. NOV currently screens at market cap $7.70B and trailing P/E 85.8.
Not investment advice. Open the DGX and NOV stock pages for the full models.
Not investment advice.